SplitApr 14, 2026, 08:32 AM
NeuroOne Medical Technologies Announces 1-for-6 Reverse Stock Split
AI Summary
NeuroOne Medical Technologies Corporation announced a 1-for-6 reverse stock split of its common stock, effective April 15, 2026. The company filed an amendment to its Certificate of Incorporation to implement this change. Stockholders had previously approved a reverse stock split at a ratio between 1-for-2 and 1-for-15, with the Board of Directors subsequently determining the 1-for-6 ratio. This action will reclassify every six existing shares into one new share, with proportional adjustments to equity incentive plans and outstanding warrants.
Key Highlights
- NeuroOne Medical Technologies Corp. filed an amendment for a reverse stock split.
- The reverse stock split ratio is 1-for-6.
- The split will be effective on April 15, 2026, at 5:00 p.m. Eastern Time.
- Stockholders approved a reverse split ratio between 1-for-2 and 1-for-15 on April 3, 2026.
- The Board of Directors approved the 1-for-6 ratio on April 3, 2026.